Status:
COMPLETED
Parenteral Nutrition Light Protection and Premature Outcomes
Lead Sponsor:
NYU Langone Health
Conditions:
Premature Birth
Eligibility:
All Genders
Up to 32 years
Phase:
NA
Brief Summary
Investigators propose a prospective study to investigate the effect of full light protection of the PN on cholestasis and other oxidative stress associated diseases in premature infants when they rece...
Eligibility Criteria
Inclusion
- Inclusion criteria
- Preterm infants \<32 weeks of gestation, who receive TPN for a minimum of 5 days
- Infants with gastrointestinal surgical problems (e.g., ileal atresia, gastroschisis), expected to receive TPN for a minimum of 5 days Exclusion criteria
- Infants who receive TPN for \<5 days
- Infants who developed cholestasis due to non-TPN-related causes
Exclusion
Key Trial Info
Start Date :
July 10 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 26 2022
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT04525872
Start Date
July 10 2020
End Date
July 26 2022
Last Update
November 1 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NYU Langone Health
New York, New York, United States, 10016